|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q81575345
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000057.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q81575345
|
|
024
|
|
|
‡a
0000-0002-6394-0783
‡2
orcid
|
|
024
|
|
|
‡a
24402431200
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q81575345
|
|
100
|
0 |
|
‡a
Elena Domínguez-Vega
‡c
researcher
‡9
en
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Elena Domínguez-Vega
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's Analysis of antibiotics by CE and their use as chiral selectors: An update
|
|
670
|
|
|
‡a
Author's Capillary electrophoresis-tandem mass spectrometry as a highly selective tool for the compositional and site-specific assessment of multiple peptide-deamidation.
|
|
670
|
|
|
‡a
Author's Capillary HILIC-MS: A New Tool for Sensitive Top-Down Proteomics.
|
|
670
|
|
|
‡a
Author's Capillary Zone Electrophoresis-Mass Spectrometry of Intact Proteins.
|
|
670
|
|
|
‡a
Author's Characterization and study of transgenic cultivars by capillary and microchip electrophoresis
|
|
670
|
|
|
‡a
Author's Characterization of conformers and dimers of antithrombin by capillary electrophoresis-quadrupole-time-of-flight mass spectrometry
|
|
670
|
|
|
‡a
Author's Chiral Discrimination of DL-Amino Acids by Trapped Ion Mobility Spectrometry after Derivatization with
|
|
670
|
|
|
‡a
Author's Chiral Discrimination of DL-Amino Acids by Trapped Ion Mobility Spectrometry after Derivatization with (+)-1-(9-Fluorenyl)ethyl Chloroformate
|
|
670
|
|
|
‡a
Author's Development of a CE-ESI-ITMS method for the enantiomeric determination of the non-protein amino acid ornithine.
|
|
670
|
|
|
‡a
Author's Enantiomeric separation of FMOC-amino acids by nano-LC and CEC using a new chiral stationary phase, cellulose tris(3-chloro-4-methylphenylcarbamate)
|
|
670
|
|
|
‡a
Author's Enantiomeric separation of ornithine in complex mixtures of amino acids by EKC with off-line derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate.
|
|
670
|
|
|
‡a
Author's Erratum to: Monitoring antigenic protein integrity during glycoconjugate vaccine synthesis using capillary electrophoresis-mass spectrometry.
|
|
670
|
|
|
‡a
Author's Evaluation of capillary electrophoresis-mass spectrometry for the analysis of the conformational heterogeneity of intact proteins using beta2-microglobulin as model compound
|
|
670
|
|
|
‡a
Author's Evaluation of new cellulose-based chiral stationary phases Sepapak-2 and Sepapak-4 for the enantiomeric separation of pesticides by nano liquid chromatography and capillary electrochromatography.
|
|
670
|
|
|
‡a
Author's Fast derivatization of the non-protein amino acid ornithine with FITC using an ultrasound probe prior to enantiomeric determination in food supplements by EKC.
|
|
670
|
|
|
‡a
Author's Fast determination of the functional peptide soymetide in different soybean derived foods by capillary-high performance liquid chromatography
|
|
670
|
|
|
‡a
Author's First approach based on direct ultrasonic assisted enzymatic digestion and capillary-high performance liquid chromatography for the peptide mapping of soybean proteins
|
|
670
|
|
|
‡a
Author's Glycoform-resolved FcɣRIIIa affinity chromatography-mass spectrometry
|
|
670
|
|
|
‡a
Author's Heterogeneity assessment of antibody-derived therapeutics at the intact and middle-up level by low-flow sheathless capillary electrophoresis-mass spectrometry
|
|
670
|
|
|
‡a
Author's High-resolution glycoform profiling of intact therapeutic proteins by hydrophilic interaction chromatography-mass spectrometry.
|
|
670
|
|
|
‡a
Author's Hydrophilic interaction liquid chromatography-mass spectrometry as a new tool for the characterization of intact semi-synthetic glycoproteins.
|
|
670
|
|
|
‡a
Author's Linking the concentrations of itraconazole and 2-hydroxypropyl-β-cyclodextrin in human intestinal fluids after oral intake of Sporanox®
|
|
670
|
|
|
‡a
Author's Low-picomolar analysis of peptides by on-line coupling of fritless solid-phase extraction to sheathless capillary electrophoresis-mass spectrometry.
|
|
670
|
|
|
‡a
Author's Media on-demand: Continuous reconstitution of a chemically defined media directly from solids
|
|
670
|
|
|
‡a
Author's Monitoring antigenic protein integrity during glycoconjugate vaccine synthesis using capillary electrophoresis-mass spectrometry
|
|
670
|
|
|
‡a
Author's Native Structural and Functional Proteoform Characterization of the Prolyl-Alanyl-Specific Endoprotease EndoPro from <i>Aspergillus niger</i>
|
|
670
|
|
|
‡a
Author's Potential of vancomycin for the enantiomeric resolution of FMOC-amino acids by capillary electrophoresis-ion-trap-mass spectrometry
|
|
670
|
|
|
‡a
Author's Recent advances in CE analysis of antibiotics and its use as chiral selectors.
|
|
670
|
|
|
‡a
Author's Recent advances in the analysis of antibiotics by CE and CEC.
|
|
670
|
|
|
‡a
Author's Simultaneous assessment of protein heterogeneity and affinity by capillary electrophoresis-mass spectrometry
|
|
670
|
|
|
‡a
Author's Site-specific N- and O-glycosylation analysis of atacicept
|
|
670
|
|
|
‡a
Author's The impact of guest compounds on cyclodextrin aggregation behavior: A series of structurally related parabens.
|
|
909
|
|
|
‡a
(orcid) 0000000263940783
‡9
1
|
|
909
|
|
|
‡a
(scopus) 24402431200
‡9
1
|
|
919
|
|
|
‡a
analysisofantibioticsbyceandtheiruseaschiralselectorsanupdate
‡A
Analysis of antibiotics by CE and their use as chiral selectors: An update
‡9
1
|
|
919
|
|
|
‡a
capillaryelectrophoresistandemmassspectrometryasahighlyselectivetoolforthecompositionalandsitespecificassessmentofmultiplepeptidedeamidation
‡A
Capillary electrophoresis-tandem mass spectrometry as a highly selective tool for the compositional and site-specific assessment of multiple peptide-deamidation.
‡9
1
|
|
919
|
|
|
‡a
capillaryhilicmsanewtoolforsensitivetopdownproteomics
‡A
Capillary HILIC-MS: A New Tool for Sensitive Top-Down Proteomics.
‡9
1
|
|
919
|
|
|
‡a
capillaryzoneelectrophoresismassspectrometryofintactproteins
‡A
Capillary Zone Electrophoresis-Mass Spectrometry of Intact Proteins.
‡9
1
|
|
919
|
|
|
‡a
characterizationandstudyoftransgeniccultivarsbycapillaryandmicrochipelectrophoresis
‡A
Characterization and study of transgenic cultivars by capillary and microchip electrophoresis
‡9
1
|
|
919
|
|
|
‡a
characterizationofconformersanddimersofantithrombinbycapillaryelectrophoresisquadrupoletimeofflightmassspectrometry
‡A
Characterization of conformers and dimers of antithrombin by capillary electrophoresis-quadrupole-time-of-flight mass spectrometry
‡9
1
|
|
919
|
|
|
‡a
chiraldiscriminationof550aminoacidsbytrappedionmobilityspectrometryafterderivatizationwith
‡A
Chiral Discrimination of DL-Amino Acids by Trapped Ion Mobility Spectrometry after Derivatization with
‡9
1
|
|
919
|
|
|
‡a
chiraldiscriminationof550aminoacidsbytrappedionmobilityspectrometryafterderivatizationwith+19fluorenylethylchloroformate
‡A
Chiral Discrimination of DL-Amino Acids by Trapped Ion Mobility Spectrometry after Derivatization with (+)-1-(9-Fluorenyl)ethyl Chloroformate
‡9
1
|
|
919
|
|
|
‡a
developmentofaceesiitmsmethodfortheenantiomericdeterminationofthenonproteinaminoacidornithine
‡A
Development of a CE-ESI-ITMS method for the enantiomeric determination of the non-protein amino acid ornithine.
‡9
1
|
|
919
|
|
|
‡a
enantiomericseparationoffmocaminoacidsbynanolcandcecusinganewchiralstationaryphasecellulosetris3chloro4methylphenylcarbamate
‡A
Enantiomeric separation of FMOC-amino acids by nano-LC and CEC using a new chiral stationary phase, cellulose tris(3-chloro-4-methylphenylcarbamate)
‡9
1
|
|
919
|
|
|
‡a
enantiomericseparationofornithineincomplexmixturesofaminoacidsbyekcwithofflinederivatizationwith6aminoquinolylnhydroxysuccinimidylcarbamate
‡A
Enantiomeric separation of ornithine in complex mixtures of amino acids by EKC with off-line derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate.
‡9
1
|
|
919
|
|
|
‡a
erratumtomonitoringantigenicproteinintegrityduringglycoconjugatevaccinesynthesisusingcapillaryelectrophoresismassspectrometry
‡A
Erratum to: Monitoring antigenic protein integrity during glycoconjugate vaccine synthesis using capillary electrophoresis-mass spectrometry.
‡9
1
|
|
919
|
|
|
‡a
evaluationofcapillaryelectrophoresismassspectrometryfortheanalysisoftheconformationalheterogeneityofintactproteinsusingbeta2microglobulinasmodelcompound
‡A
Evaluation of capillary electrophoresis-mass spectrometry for the analysis of the conformational heterogeneity of intact proteins using beta2-microglobulin as model compound
‡9
1
|
|
919
|
|
|
‡a
evaluationofnewcellulosebasedchiralstationaryphasessepapak2andsepapak4fortheenantiomericseparationofpesticidesbynanoliquidchromatographyandcapillaryelectrochromatography
‡A
Evaluation of new cellulose-based chiral stationary phases Sepapak-2 and Sepapak-4 for the enantiomeric separation of pesticides by nano liquid chromatography and capillary electrochromatography.
‡9
1
|
|
919
|
|
|
‡a
fastderivatizationofthenonproteinaminoacidornithinewithfitcusinganultrasoundprobepriortoenantiomericdeterminationinfoodsupplementsbyekc
‡A
Fast derivatization of the non-protein amino acid ornithine with FITC using an ultrasound probe prior to enantiomeric determination in food supplements by EKC.
‡9
1
|
|
919
|
|
|
‡a
fastdeterminationofthefunctionalpeptidesoymetideindifferentsoybeanderivedfoodsbycapillaryhighperformanceliquidchromatography
‡A
Fast determination of the functional peptide soymetide in different soybean derived foods by capillary-high performance liquid chromatography
‡9
1
|
|
919
|
|
|
‡a
1approachbasedondirectultrasonicassistedenzymaticdigestionandcapillaryhighperformanceliquidchromatographyforthepeptidemappingofsoybeanproteins
‡A
First approach based on direct ultrasonic assisted enzymatic digestion and capillary-high performance liquid chromatography for the peptide mapping of soybean proteins
‡9
1
|
|
919
|
|
|
‡a
glycoformresolvedfcɣriiiaaffinitychromatographymassspectrometry
‡A
Glycoform-resolved FcɣRIIIa affinity chromatography-mass spectrometry
‡9
1
|
|
919
|
|
|
‡a
heterogeneityassessmentofantibodyderivedtherapeuticsattheintactandmiddleuplevelbylowflowsheathlesscapillaryelectrophoresismassspectrometry
‡A
Heterogeneity assessment of antibody-derived therapeutics at the intact and middle-up level by low-flow sheathless capillary electrophoresis-mass spectrometry
‡9
1
|
|
919
|
|
|
‡a
highresolutionglycoformprofilingofintacttherapeuticproteinsbyhydrophilicinteractionchromatographymassspectrometry
‡A
High-resolution glycoform profiling of intact therapeutic proteins by hydrophilic interaction chromatography-mass spectrometry.
‡9
1
|
|
919
|
|
|
‡a
hydrophilicinteractionliquidchromatographymassspectrometryasanewtoolforthecharacterizationofintactsemisyntheticglycoproteins
‡A
Hydrophilic interaction liquid chromatography-mass spectrometry as a new tool for the characterization of intact semi-synthetic glycoproteins.
‡9
1
|
|
919
|
|
|
‡a
linkingtheconcentrationsofitraconazoleand2hydroxypropylβcyclodextrininhumanintestinalfluidsafteroralintakeofsporanox
‡A
Linking the concentrations of itraconazole and 2-hydroxypropyl-β-cyclodextrin in human intestinal fluids after oral intake of Sporanox®
‡9
1
|
|
919
|
|
|
‡a
lowpicomolaranalysisofpeptidesbyonlinecouplingoffritlesssolidphaseextractiontosheathlesscapillaryelectrophoresismassspectrometry
‡A
Low-picomolar analysis of peptides by on-line coupling of fritless solid-phase extraction to sheathless capillary electrophoresis-mass spectrometry.
‡9
1
|
|
919
|
|
|
‡a
mediaondemandcontinuousreconstitutionofachemicallydefinedmediadirectlyfromsolids
‡A
Media on-demand: Continuous reconstitution of a chemically defined media directly from solids
‡9
1
|
|
919
|
|
|
‡a
monitoringantigenicproteinintegrityduringglycoconjugatevaccinesynthesisusingcapillaryelectrophoresismassspectrometry
‡A
Monitoring antigenic protein integrity during glycoconjugate vaccine synthesis using capillary electrophoresis-mass spectrometry
‡9
1
|
|
919
|
|
|
‡a
nativestructuralandfunctionalproteoformcharacterizationoftheprolylalanylspecificendoproteaseendoprofrom1aspergillusniger1
‡A
Native Structural and Functional Proteoform Characterization of the Prolyl-Alanyl-Specific Endoprotease EndoPro from <i>Aspergillus niger</i>
‡9
1
|
|
919
|
|
|
‡a
potentialofvancomycinfortheenantiomericresolutionoffmocaminoacidsbycapillaryelectrophoresisiontrapmassspectrometry
‡A
Potential of vancomycin for the enantiomeric resolution of FMOC-amino acids by capillary electrophoresis-ion-trap-mass spectrometry
‡9
1
|
|
919
|
|
|
‡a
recentadvancesinceanalysisofantibioticsanditsuseaschiralselectors
‡A
Recent advances in CE analysis of antibiotics and its use as chiral selectors.
‡9
1
|
|
919
|
|
|
‡a
recentadvancesintheanalysisofantibioticsbyceandcec
‡A
Recent advances in the analysis of antibiotics by CE and CEC.
‡9
1
|
|
919
|
|
|
‡a
simultaneousassessmentofproteinheterogeneityandaffinitybycapillaryelectrophoresismassspectrometry
‡A
Simultaneous assessment of protein heterogeneity and affinity by capillary electrophoresis-mass spectrometry
‡9
1
|
|
919
|
|
|
‡a
sitespecificnandoglycosylationanalysisofatacicept
‡A
Site-specific N- and O-glycosylation analysis of atacicept
‡9
1
|
|
919
|
|
|
‡a
impactofguestcompoundsoncyclodextrinaggregationbehavioraseriesofstructurallyrelatedparabens
‡A
The impact of guest compounds on cyclodextrin aggregation behavior: A series of structurally related parabens.
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
DNB|1158999267
|
|
996
|
|
|
‡2
ISNI|0000000034337358
|
|
996
|
|
|
‡2
ISNI|0000000121029775
|
|
996
|
|
|
‡2
ISNI|0000000060736539
|
|
996
|
|
|
‡2
BNF|14627091
|
|
996
|
|
|
‡2
BNE|XX6239421
|
|
996
|
|
|
‡2
ISNI|0000000116971715
|
|
996
|
|
|
‡2
BNE|XX4675932
|
|
996
|
|
|
‡2
BNCHL|10000000000000000233609
|
|
996
|
|
|
‡2
RERO|A012791305
|
|
996
|
|
|
‡2
BNE|XX1755752
|
|
996
|
|
|
‡2
BIBSYS|99002475
|
|
996
|
|
|
‡2
PLWABN|9810545451405606
|
|
996
|
|
|
‡2
BNE|XX1151343
|
|
996
|
|
|
‡2
ISNI|0000000032029562
|
|
996
|
|
|
‡2
ISNI|0000000080323141
|
|
996
|
|
|
‡2
NUKAT|n 97017751
|
|
996
|
|
|
‡2
NII|DA00520758
|
|
996
|
|
|
‡2
PTBNP|214532
|
|
996
|
|
|
‡2
SUDOC|078649250
|
|
996
|
|
|
‡2
LC|n 96007564
|
|
996
|
|
|
‡2
ISNI|0000000041351932
|
|
996
|
|
|
‡2
LC|n 2001106396
|
|
996
|
|
|
‡2
SUDOC|083776168
|
|
996
|
|
|
‡2
BNC|981061111674406706
|
|
996
|
|
|
‡2
ISNI|0000000109260755
|
|
996
|
|
|
‡2
NUKAT|n 99008572
|
|
996
|
|
|
‡2
LC|nb2008014970
|
|
996
|
|
|
‡2
SUDOC|085829854
|
|
996
|
|
|
‡2
CAOONL|ncf11506470
|
|
996
|
|
|
‡2
NUKAT|n 2015135139
|
|
996
|
|
|
‡2
ISNI|0000000430776619
|
|
996
|
|
|
‡2
BNF|15519764
|
|
996
|
|
|
‡2
LC|n 2007050125
|
|
996
|
|
|
‡2
NTA|109369335
|
|
996
|
|
|
‡2
DNB|1275534449
|
|
996
|
|
|
‡2
LC|no2001094465
|
|
996
|
|
|
‡2
ISNI|000000040961608X
|
|
996
|
|
|
‡2
BNE|XX1222703
|
|
996
|
|
|
‡2
ISNI|0000000399977892
|
|
996
|
|
|
‡2
BIBSYS|90131830
|
|
996
|
|
|
‡2
BNCHL|10000000000000000069121
|
|
996
|
|
|
‡2
LC|no2017111720
|
|
996
|
|
|
‡2
DNB|1057229407
|
|
996
|
|
|
‡2
ISNI|0000000114468091
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
